Endocrine System Diseases
119
13
21
67
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
29 trials with published results (24%)
Research Maturity
67 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
7.6%
9 terminated out of 119 trials
88.2%
+1.6% vs benchmark
22%
26 trials in Phase 3/4
43%
29 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 67 completed trials
Clinical Trials (119)
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Endocrine and Metabolic Late Effects After Childhood Brain Tumor Treatment
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency
A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency
A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism
Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease
Financial Navigation and Peer Support to Improve Diabetes Outcomes
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism